Projects funded by the NCN

A convenient and verstile preparation of bioconjugates by formation of functionalized unsymmetrical disulfides under aqu...

Call: OPUS 5 , Panel: ST5

Principal investigator: prof. Janusz Rachoń

Politechnika Gdańska, Wydział Chemiczny

Bioconjugates of 103Pd nanostructures for targeted Auger electron therapy.

Call: OPUS 23 , Panel: ST5

Principal investigator: dr hab. Agnieszka Majkowska-Pilip

Instytut Chemii i Techniki Jądrowej

Bioconjugates of gold nanoparticles coated by 197/197mHg for Auger electron targeted therapy

Call: PRELUDIUM 20 , Panel: ST5

Principal investigator: Emilia Majka

Instytut Chemii i Techniki Jądrowej

Bioconjugates labeled with alpha- and beta-particle emitting radionuclides as potential radiopharmaceuticals in Targeted...

Call: SONATA BIS 9 , Panel: ST4

Principal investigator: dr hab. Marek Pruszyński

Instytut Chemii i Techniki Jądrowej

Anticancer Trojan horses: Application of the bioconjugation idea to invent new anticancer drugs

Call: UWERTURA 3 , Panel: ST4

Principal investigator: dr Michał Antoszczak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Quantum dots for biomedical applications

Call: UWERTURA 1 , Panel: ST5

Principal investigator: prof. Adriana Zaleska-Medynska

Uniwersytet Gdański, Wydział Chemii

Novel cationic photosensitizers for antimicrobial photodynamic therapy (aPDT)

Call: PRELUDIUM 12 , Panel: ST5

Principal investigator: Magdalena Obłoza

Uniwersytet Jagielloński, Wydział Chemii

Bioconjugates of multimodal nanoparticles for targeted alpha and hyperthermia therapy. Synthesis, retention studies of r...

Call: PRELUDIUM 9 , Panel: ST4

Principal investigator: Edyta Cędrowska

Instytut Chemii i Techniki Jądrowej